Community lists
キュレーション · ヘルスケア

Biotech

InspectStocks 編集Published 2026年10月14日19 companies0 followers

Drug developers with approved medicines, built mainly on biologic and genetic science.

AI モデルの助けを借りてグループ分けし、編集部が確認しました。各企業の下の一行が、ここに入っている理由を説明します。

Sign in to followSign in to copy
Download image
カードティア
A
  • GILDGilead Sciences
    $169.73+40.9% 1Y

    Sells medicines for HIV, liver disease and cancer

  • BIIBBiogen
    $253.39+56.9% 1Y

    Develops and sells therapies for neurological diseases

  • NBIXNeurocrine Biosciences
    $174.35+18.7% 1Y

    Develops and sells therapies for neurological and endocrine disorders

  • EXELExelixis
    $70.71+62.2% 1Y

    Develops and sells cancer therapies

  • JAZZJazz Pharmaceuticals
    $248.18+81.5% 1Y

    Develops and sells neuroscience and oncology therapies

  • HALOHalozyme Therapeutics
    $101.69+44.0% 1Y

    Licenses drug delivery technology and sells enzyme-based therapies

  • KRYSKrystal Biotech
    $308.82+52.1% 1Y

    Develops and sells topical gene therapies for rare diseases

  • CORTCorcept Therapeutics
    $74.52-4.9% 1Y

    Develops and sells cortisol-modulating therapies

B
  • VRTXVertex Pharmaceuticals
    $547.02+26.0% 1Y

    Develops and sells cystic fibrosis and other medicines

  • ALNY成長が鈍っているため 1 段階下げAlnylam Pharmaceuticals
    $159.80-64.7% 1Y

    Develops and sells RNAi therapeutics

  • BBIOBridgeBio Pharma
    $79.53+20.1% 1Y

    Develops therapies for genetic diseases

  • BMRNBioMarin Pharmaceutical
    $58.32+5.4% 1Y

    Develops and sells therapies for rare genetic diseases

C
  • REGNRegeneron Pharmaceuticals
    $959.45+41.5% 1Y

    Develops and sells antibody therapies for eye, allergy and cancer conditions

  • MRNAModerna
    $248.70+831.1% 1Y

    Develops mRNA vaccines and therapies

  • INSMInsmed
    $120.64-37.9% 1Y

    Develops and sells therapies for rare lung diseases

  • UTHR成長が鈍っているため 1 段階下げUnited Therapeutics
    $595.58+29.0% 1Y

    Sells therapies for pulmonary arterial hypertension

  • INCYIncyte
    $122.23+12.9% 1Y

    Develops and sells oncology and inflammation therapies

D
  • ASNDAscendis Pharma A/S
    $259.10+30.1% 1Y

    Develops and sells endocrinology rare disease therapies

F
  • BNTXBioNTech
    $87.64-21.5% 1Y

    Develops mRNA vaccines and cancer therapies

DiscussionNo comments yet

Sign in to join the discussion

Be civil and stick to the companies. Comments are opinions, not advice.

    Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.